Table of Contents 3
List of Tables 4
List of Figures 4
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
ExpreS2ion Biotech Forms Joint Venture with NextGen Vaccines 12
Licensing Agreements 13
Expres2ion Biotech Enters into Licensing Agreement with University of Pennsylvania 13
Integrated BioTherapeutics Enters into Licensing Agreement with ExpreS2ion Biotech 14
ExpreS2ion Biotech Enters into Licensing Agreement with Abivax 15
VaxInnate Enters into Licensing Agreement with ExpreS2ion Biotech 16
Expres2ion Enters into Licensing Agreement with Gene Center at Ludwig Maximilians Universitat Munchen 17
ExpreS2ion Biotech Enters Into Licensing Agreement With London Research Institute For Protein Production Technology 18
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 19
Equity Offering 20
ExpreS2ion Biotech Raises USD0.5 Million in Rights Offering of Shares 20
ExpreS2ion Biotech Raises USD2.2 Million in IPO 21
Expres2ion Biotechnologies ApS - Key Competitors 22
Expres2ion Biotechnologies ApS - Key Employees 23
Expres2ion Biotechnologies ApS - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 24, 2018: ExpreS2ion Biotech Holding: Publication of financial report for January - June 2018 25
Corporate Communications 26
Aug 17, 2018: ExpreS2ion appoints CBO and IR partner 26
Government and Public Interest 27
Mar 30, 2017: Eurostars funding for novel Zika vaccine 27
Jan 23, 2017: ExpreS2ion announces the initial approval of a Eurostars grant application, OptiFemVac, with main focus on the development of a Zika vaccine 28
Product News 29
Apr 20, 2018: ExpreS2ion's U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product 29
Other Significant Developments 30
Feb 08, 2018: ExpreS2ion Biotech Holding announces start of subscription period in the rights issue 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
ExpreS2ion Biotech Forms Joint Venture with NextGen Vaccines 12
Expres2ion Biotech Enters into Licensing Agreement with University of Pennsylvania 13
Integrated BioTherapeutics Enters into Licensing Agreement with ExpreS2ion Biotech 14
ExpreS2ion Biotech Enters into Licensing Agreement with Abivax 15
VaxInnate Enters into Licensing Agreement with ExpreS2ion Biotech 16
Expres2ion Enters into Licensing Agreement with Gene Center at Ludwig Maximilians Universitat Munchen 17
ExpreS2ion Biotech Enters Into Licensing Agreement With London Research Institute For Protein Production Technology 18
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 19
ExpreS2ion Biotech Raises USD0.5 Million in Rights Offering of Shares 20
ExpreS2ion Biotech Raises USD2.2 Million in IPO 21
Expres2ion Biotechnologies ApS, Key Competitors 22
Expres2ion Biotechnologies ApS, Key Employees 23
Expres2ion Biotechnologies ApS, Joint Venture 24

List of Figures
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Expres2ion Biotechnologies ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Expres2ion Biotechnologies ApS, Medical Devices Deals, 2012 to YTD 2018 9